Aurora Health Care’s Post

New Case Report! "Conservative Management of LVAD-Associated Ventricular Pseudoaneurysm" by Drs. Marvin Kajy, Connor Kerndt, Paul Weber, Marzia Leacche & Renzo Loyaga Rendon. This case portrays a patient suffering from a left ventricular pseudoaneurysm after HeartMate-III implantation that was not amenable to surgical repair due to heightened surgical risk. This documents the first pseudoaneurysm associated with the HeartMate-III in available literature and describes a novel management strategy of documented nonoperative course of LVAD-associated pseudoaneurysm, with the patient surviving 56+ months with medical optimization and management. See videos at Methodist DeBakey Cardiovascular Journal https://lnkd.in/gv7fntPm

our newly indicated advanced hemodynamic monitoring solutions for pediatric patients!

Tilt procedures in the operating room can present unique challenges for perioperative teams. For patients, tilt positions can increase the risk of falls or sliding.¹ During Patient Safety Awareness Week, learn how you can reposition, tilt and transfer your patients with confidence in the OR with our Multi-Position MATS: https://bit.ly/3TCQi8I Reference: 1. Chitlik A, Safe Positioning for Robotic-Assisted Laparoscopic Prostatectomy, AORN Journal 2011;94(1):37-48.

For those interested, we just published a manuscript investigating intraoperative opioid variation. Key takeaways: there exists variation in opioid administration within and across surgical procedures, with substantial contributions to variation in intraoperative opioid administration at clinician, hospital, and patient levels, underscoring the need to consider these factors when evaluating opioid-reducing strategies. https://lnkd.in/eJj4jUWQ

These inspiring words are shared in the Roper St. Francis Wound Care department from medical director Mary Elizabeth Hanley DO, FUHM,CWSP,FAPWCA. You could be the next patient added to the "healed" list! The wound care department treats all kinds of complex, non-healing wounds, including: 🦶 Diabetic foot ulcers ❗ Radiation therapy wounds 🩹 Surgical incisions ⚠️ Wounds caused by poor circulation and more. Learn about the wound care and hyperbaric medicine program here: https://bit.ly/4a1JOpt

Abbott wins FDA clearance for bedside blood concussion test 🧠 Each year, an estimated 3.8 million concussions occur, yet nearly half of them go unnoticed and untreated. It's crucial for everyone—not just athletes—to understand the seriousness of concussions and their symptoms. 🚑 Despite increased attention to head injuries in sports, concussions can still slip through the cracks due to inadequate medical protocols or unusual symptoms. 🔬 Exciting news from Abbott! They've just received FDA clearance for a revolutionary whole blood concussion test that can be conducted bedside. 👩⚕️ This marks the first time the FDA has authorized a test using whole blood to evaluate mild traumatic brain injuries, offering quicker diagnosis times and accessibility outside of hospital ERs. 🏥 Abbott's breakthrough paves the way for faster concussion diagnoses, potentially reaching beyond emergency rooms and into various healthcare settings. 🌟 Abbott's long-term vision includes developing tests suitable for non-healthcare settings, like sidelines of sporting events, further enhancing concussion management. #ConcussionAwareness #Healthcare #PublicHealth #SportsSafety #InjuryPrevention #MedicalProtocol #MedicalInnovation #FDAApproval #HealthTech #TraumaticBrainInjury #HealthcareAccessibility #MedicalAdvancement #HealthcareTechnology #PatientCare #MedicalProgress #SportsMedicine #AthleteSafety #InnovativeHealthcare https://lnkd.in/eAjcDdiY

Join us on Tuesday, June 11 for an all new webinar! Implanted Vascular Access Devices: Back to the Basics in Care and Management. Over 2 billion intravascular devices are inserted globally each year, and determining optimal maintenance protocols is challenging. Literature cites late complications of central venous access devices (CVAD) range from 7.2% to 32.1%. Implanted vascular access devices (IVADs) are quoted to have lower risk than other CVADs but are not risk-free. Despite risk, patients often retain their devices for extended periods. In this session, we will review the basics of care and management of IVADs and let evidence-based practice guide the way to minimizing potential complications. Register today at: https://buff.ly/3Va3jrg

Join us on Tuesday, June 11 for an all new webinar! Implanted Vascular Access Devices: Back to the Basics in Care and Management. Over 2 billion intravascular devices are inserted globally each year, and determining optimal maintenance protocols is challenging. Literature cites late complications of central venous access devices (CVAD) range from 7.2% to 32.1%. Implanted vascular access devices (IVADs) are quoted to have lower risk than other CVADs but are not risk-free. Despite risk, patients often retain their devices for extended periods. In this session, we will review the basics of care and management of IVADs and let evidence-based practice guide the way to minimizing potential complications. Register today at: https://buff.ly/3Va3jrg

Join us on Tuesday, June 11 for an all new webinar! Implanted Vascular Access Devices: Back to the Basics in Care and Management. Over 2 billion intravascular devices are inserted globally each year, and determining optimal maintenance protocols is challenging. Literature cites late complications of central venous access devices (CVAD) range from 7.2% to 32.1%. Implanted vascular access devices (IVADs) are quoted to have lower risk than other CVADs but are not risk-free. Despite risk, patients often retain their devices for extended periods. In this session, we will review the basics of care and management of IVADs and let evidence-based practice guide the way to minimizing potential complications. Register today at: https://buff.ly/3Va3jrg

Presenting at #InnovationSF23: Max G. Ostermeier of Implandata Ophthalmic Products (San Diego, California, USA) who are transforming the care of glaucoma patients by introducing remote disease monitoring and management with their game-changing EYEMATE system. Eye doctors are enabled to remotely manage their patients and to personalize therapy. What the CEOs read: bit.ly/3QvOw6I